Evaluation of efficacy on pigmentation by R1110 using In vivo confocal laser microscopy.

Not Applicable

• Conditions: solar lentigo or melasma

• Registration Number: JPRN-UMIN000005379
• Lead Sponsor: Rohto Pharmaceutical Co., LTD

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-04-13
• Study Completion: 2011-10-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Not provided

Exclusion Criteria

1) Subjects who used hydroquinone products or retinoic acid products (concentration: more than 0.1%) within the past 3 months. 2) Subjects who used the internal medicine containing tranexamic acid or L- cysteine or vitamin C or E within the past 3 months. 3) Subjects who underwent the plastic treatment or the beauty salon treatment within the past 2 months. 4) Subjects who used the quasi drugs or the cosmetic products (e.g. the products containing vitamin C or arbutin, etc. Except for hydroquinone) for whitening within the past 1 month from informed consent. 5) Subjects who underwent the hormone complement treatment within the past 1 month. 6) Subjects who are exposed to the severe ultraviolet rays of the sun. 7) Subjects with severe diseases, e.g. hepatic disease and renal disease. 8) Subjects with allergy or atopic dermatitis, and a history of contact dermatitis. 9) Females who are pregnant or breast feeding, and females of childbearing potential. 10) Subjects who are considered ineligible by the principal or other investigators.

Study & Design

• Study Type: Interventional
• Study Design: Not specified